Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27114888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ivan Salido-Guadarrama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioinformática y Análisis Estadisticos, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México 11000, Mex…. Hauptthemen laut MEDLINE: Endometriosis, Genomics, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Sciences, Humanities, Technology and Innovation.
Abstract (Originalsprache)
Endometriosis affects an estimated 5–10% of women of reproductive age and presents with substantial clinical and biological heterogeneity. Recent clinical guidelines have shifted toward symptom-guided diagnosis supported by expert imaging, moving away from mandatory diagnostic laparoscopy and redefining the evidentiary standards for evaluating new diagnostic technologies. Advances across omics domains, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, extracellular vesicle profiling, microbiome research, and multi-omics integration, have deepened understanding of lesion biology, immune dysregulation, metabolic alterations, and progesterone resistance. However, translation of these molecular insights into clinically actionable tools remains limited. Most candidate biomarkers remain at discovery or internal/developer-led validation stages, constrained by small sample sizes, heterogeneous analytical platforms, incomplete control of confounding variables, and limited independent multicenter validation. In this review, we apply a four-tier evidence-maturity framework, spanning discovery, internal or developer-led validation, independent external validation, and demonstrated clinical utility, to classify omics-based diagnostic, prognostic, and treatment-response applications in endometriosis. We also distinguish potential clinical roles, including triage, adjunctive testing, and replacement-test evaluation, each requiring different validation standards and performance thresholds. Salivary microRNA currently represents the most clinically advanced diagnostic omics candidate, but the available evidence remains developer-led and is best classified as advanced Tier 2/Tier 2+ rather than independent Tier 3 validation. Prognostic and treatment-response applications are less mature and remain discovery-stage because prospective patient-level longitudinal validation and biomarker-stratified treatment trials are lacking. Overall, no omics-derived biomarker has yet achieved independent Tier 3 validation or Tier 4 readiness for routine clinical implementation. At present, omics approaches should be regarded primarily as research and translational prioritization tools rather than determinants of routine clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Bioinformática y Análisis Estadisticos, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México 11000, Mexico.
- Departamento de Ginecología Quirúrgica, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
- Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 11000, Mexico.
- Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
- Instituto Nacional de Medicina Genómica, Periférico Sur 4809, Ciudad de México 14610, Mexico.
ORCID-Profile: Ivan Salido-Guadarrama, Mauricio Rodriguez-Dorantes
Förderung
- Ministry of Sciences, Humanities, Technology and Innovation
Zitieren
APA
Salido-Guadarrama, I., Cruz-Orozco, O., Camacho-Arroyo, I., Quintero, J. C., Silvestri-Tomassoni, J. R., Sánchez-Ramírez, B., & Rodriguez-Dorantes, M. (2026). Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114888
Vancouver
Salido-Guadarrama I, Cruz-Orozco O, Camacho-Arroyo I, Quintero JC, Silvestri-Tomassoni JR, Sánchez-Ramírez B, et al. Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114888
BibTeX
@article{SalidoGuadarrama2026,
author = {Salido-Guadarrama, Ivan and Cruz-Orozco, Oliver and Camacho-Arroyo, Ignacio and Quintero, Juan Carlos and Silvestri-Tomassoni, Jose Roberto and Sánchez-Ramírez, Brenda and Rodriguez-Dorantes, Mauricio},
title = {Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27114888}
}
EUVIMED